Georgia Medicaid Substance Use Disorder Treatment (2026)

Georgia Medicaid covers the full range of substance use disorder treatment, from outpatient counseling and addiction medications to residential rehab and medically managed detox. If you or a family member has Georgia Medicaid, the treatment a doctor says is medically necessary is a covered benefit, and that includes older adults who develop a drinking problem late in life or who misuse prescription opioids or anti-anxiety medications. This guide explains what is covered, the medications for opioid and alcohol use disorder, how coverage works when someone has both Medicare and Medicaid, and the concrete steps to reach treatment in Georgia.

In This Guide

• What Georgia Medicaid Covers for Substance Use Disorder Treatment
• Coverage for Older Adults and Dual-Eligibles
• Medications for Opioid Use Disorder
• Medications for Alcohol Use Disorder
• Naloxone and Overdose Reversal
• The Federal Framework
• Georgia's Delivery System
• Pregnancy and Adolescent Treatment
• How to Access Substance Use Disorder Treatment
• Worked Examples
• Frequently Asked Questions
• Learn More

What Georgia Medicaid Covers for Substance Use Disorder Treatment

Georgia Medicaid covers substance use disorder treatment at every level of intensity. The clinical standard that decides which level a person needs is the American Society of Addiction Medicine (ASAM) Criteria, which Georgia Medicaid uses as its medical-necessity framework. An assessment scores six dimensions, including withdrawal risk, other medical conditions, and the person's living environment, and matches the patient to the right setting. Residential and inpatient care in larger facilities is paid through Georgia's Section 1115 demonstration, the route states use to fund treatment in settings the regular Medicaid rules would otherwise exclude.1

The continuum runs from brief screening to hospital-based detox.

Two delivery models sit alongside these levels for opioid use disorder. An Opioid Treatment Program (OTP) is the licensed clinic that can dispense methadone. Office-Based Opioid Treatment (OBOT) is buprenorphine prescribed in a regular clinical setting, such as a primary care office or a community health center.

Coverage for older adults and dual-eligibles

Substance use disorder does not stop at a certain age. Late-onset alcohol use disorder, misuse of prescription opioids left over from a surgery or chronic-pain regimen, and dependence on benzodiazepines prescribed for sleep or anxiety are common in older adults, and they are often missed because the symptoms can look like aging or another illness. Georgia Medicaid covers treatment for these conditions the same way it covers them at any age: the ASAM continuum, the medications, and the counseling are all available when a clinician documents medical necessity.

What changes for most older adults is how the bill is paid, because the majority of Georgians over 65 have Medicare as well.2 A person with both programs is "dually eligible." Medicare is the primary payer and pays first; Georgia Medicaid is the secondary payer that covers Medicare's deductibles and copays and pays for services Medicare does not cover, most importantly long-term custodial care. Anyone who qualifies for Medicaid automatically qualifies for Extra Help, the full Part D low-income subsidy, so drug costs are heavily reduced without a separate application.

Opioid treatment program services are a useful example of how this works for an older adult. Since January 1, 2020, Medicare Part B has covered OTP services, including methadone, buprenorphine, and naltrexone, as a bundled benefit. The beneficiary coinsurance is $0, though the annual Part B deductible ($283 in 2026) applies first.3 A person who has both Medicare and full Georgia Medicaid and receives the services through Medicaid pays nothing at all.

Georgia's dual-eligible coverage is less integrated than in some states. Dual Eligible Special Needs Plans (D-SNPs), a type of Medicare Advantage plan built for people with both coverages, operate in Georgia for 2026, including plans from UnitedHealthcare Community Plan and CareSource, though the Georgia Department of Community Health placed a moratorium on contracting with new D-SNPs effective August 1, 2025.4 Because Georgia has not adopted full Medicaid expansion, most older adults qualify for full Medicaid through the aged, blind, and disabled (ABD) pathway, and long-term supports are delivered through home- and community-based waivers such as the Community Care Services Program (CCSP) and SOURCE rather than a single integrated plan.

For the adult child arranging care for a parent: you do not have to untangle which program pays before getting help. Start with the parent's Medicaid plan or, if they are dual-eligible, their Medicare or D-SNP plan, and ask the plan's behavioral health line (listed under How to Access Substance Use Disorder Treatment) to coordinate an assessment and a referral. A parent who cannot self-advocate can authorize you to speak with providers and plans on their behalf, and substance use records carry extra confidentiality protection that a signed consent overrides for the people on the care team.

Medications for opioid use disorder

Medication is the standard of care for opioid use disorder, and Georgia Medicaid covers all three FDA-approved options. The American Society of Addiction Medicine, the National Institute on Drug Abuse, and the Substance Abuse and Mental Health Services Administration (SAMHSA) consider buprenorphine and methadone first-line, with extended-release naltrexone an alternative.

Buprenorphine

Buprenorphine is the most widely available opioid use disorder medication. The Mainstreaming Addiction Treatment (MATE) Act, enacted as Section 1262 of the Consolidated Appropriations Act, 2023, eliminated the old DATA-2000 "X-waiver" effective on enactment in December 2022.5 Any practitioner who holds a current DEA registration that includes Schedule III prescribing authority may now prescribe buprenorphine for opioid use disorder, with no separate certification and no cap on patients. In practice this means a primary care physician, an OB/GYN, a nurse practitioner, or a physician assistant can offer treatment, which removed the long-standing barrier of finding a specially licensed doctor.

Georgia Medicaid covers buprenorphine/naloxone sublingual film (Suboxone and generics) as preferred on the Preferred Drug List, so the preferred form needs no prior authorization. Buprenorphine monotherapy (Subutex) is covered for pregnancy and other specific clinical situations. The monthly extended-release injection (Sublocade) is covered, typically with prior authorization documenting a stable response to the sublingual form.

Methadone

Methadone used to treat opioid use disorder may be dispensed only through a SAMHSA-certified, DEA-registered Opioid Treatment Program.6 Under 42 CFR Part 8, it cannot be prescribed at a regular pharmacy or by an office-based practitioner for opioid use disorder, although methadone for pain can be prescribed in ordinary settings. New patients dose daily on-site, then earn take-home supplies as they stabilize.

SAMHSA's 2024 final rule (amending 42 CFR Part 8), effective April 2, 2024, made the COVID-era flexibilities permanent and was the first major overhaul of the opioid treatment program rules since 2001. Stable patients may now receive up to 28 days of take-home methadone, and rigid time-in-treatment formulas no longer dictate take-home amounts.7 The rule also made telehealth available to start treatment within an OTP, using audio-only or audio-visual telehealth for buprenorphine and audio-visual telehealth for methadone, removing the requirement for an in-person physical evaluation before the first dose. Medicaid pays the OTP a bundled rate that covers the medication, counseling, and drug testing, so there is no separate pharmacy copay. OTP access in Georgia is concentrated in metro Atlanta and thinner in rural counties, a gap the take-home expansion partly eases.

Extended-release naltrexone

Vivitrol is a monthly intramuscular injection that blocks opioid receptors. Because it can trigger withdrawal if opioids are still in the system, starting it requires a 7 to 10 day opioid-free period (or about 4 days for short-acting opioids), which is the main barrier to beginning treatment. Georgia Medicaid covers it through the medical benefit or specialty pharmacy, with prior authorization.

A note on telehealth beyond the OTP setting:8 the broader federal flexibility that lets DEA-registered prescribers start controlled medications, including office-based buprenorphine, entirely by telemedicine without any in-person evaluation is a temporary rule, not a permanent one. In its most recent action, published December 31, 2025, the DEA and HHS extended that flexibility through December 31, 2026. Patients beginning buprenorphine by telehealth in a regular clinic (rather than through an OTP) should confirm the current rule with their prescriber.

Medications for alcohol use disorder

Georgia Medicaid covers the FDA-approved medications for alcohol use disorder, which are underused relative to how well they work, especially in older adults for whom heavy drinking carries added risk.

Topiramate, gabapentin, and baclofen are sometimes used off-label for alcohol use disorder; coverage varies and may require documentation that the approved medications were tried first.

Naloxone and overdose reversal

Naloxone is the medication that reverses an opioid overdose, and it is broadly accessible. In 2023 the FDA approved Narcan (naloxone 4 mg nasal spray) for over-the-counter sale, the first naloxone product available without a prescription, and it is now sold over the counter in all 50 states.9 Georgia Medicaid covers naloxone through the pharmacy benefit. Georgia also has a statewide naloxone standing order through the Department of Public Health, which lets a pharmacist dispense it without an individual prescription, and it is available through community organizations and harm-reduction programs. Confirm any cost-sharing with your Georgia Medicaid plan, since the over-the-counter product is also stocked at retail pharmacies for anyone to buy.

The federal framework

A handful of federal rules govern what Georgia Medicaid must and may cover for substance use disorder. They matter to a reader mainly because they explain why residential treatment is covered, why a primary care doctor can now prescribe buprenorphine, and why addiction benefits cannot be more restrictive than other medical benefits.

The IMD exclusion and residential treatment

A long-standing rule called the "IMD exclusion" bars federal Medicaid payment for most services to adults under 65 who are patients in an Institution for Mental Diseases, defined as a facility of more than 16 beds primarily treating mental illness, which includes substance use disorder.10 Because most residential rehab facilities have more than 16 beds, this rule was for decades the single largest barrier to covering residential addiction treatment.

Section 5052 of the SUPPORT for Patients and Communities Act of 2018 created a state-plan option (Social Security Act Section 1915(l)) letting states pay for SUD treatment in these facilities for up to 30 days in any 12-month period for adults aged 21 to 64. The window to newly elect that state-plan option ran only through September 30, 2023 and has closed.11,1 The route states use today is the Section 1115 SUD demonstration, under which more than 30 states, including Georgia, pay for short-term residential and inpatient care in these settings provided the programs meet ASAM standards and CMS approves the state's plan. The practical takeaway for a Georgia reader: residential rehab is covered, but it is time-limited, and longer stays may require a smaller (non-IMD) facility or a step down to intensive outpatient.

Required coverage of addiction medications

Section 1006(b) of the same 2018 law made coverage of medication-assisted treatment a mandatory Medicaid benefit nationwide for the period from October 1, 2020 through September 30, 2025.12 That federal mandate window has now closed, but Georgia Medicaid continues to cover the FDA-approved opioid and alcohol use disorder medications described above.

Parity: addiction benefits cannot be more restrictive

The Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) requires health plans that cover mental health and substance use disorder benefits to apply copays, visit limits, prior authorization, and medical-necessity rules no more restrictively than they do for medical and surgical benefits.13 A 2016 federal final rule applied these standards to Medicaid managed care, so Georgia's care management organizations must meet parity.14 The Consolidated Appropriations Act, 2021 added a requirement that plans document a comparative analysis of their non-quantitative limits. A 2024 final rule sought to strengthen those requirements, but on May 15, 2025 the federal departments announced they will not enforce the portions of the 2024 rule that are new relative to the 2013 rule while litigation is pending; the underlying 2008 statute and the 2013 rule remain in effect.

Parity compliance in practice has lagged: a 2024 HHS Office of Inspector General report found that none of the eight states it reviewed had built the required parity provisions into their Medicaid managed care contracts by the federal compliance date.15 Georgia added its own layer in 2022. The Georgia Mental Health Parity Act (House Bill 1013), signed April 4, 2022 and effective July 1, 2022, requires state-regulated insurers to cover mental health and substance use disorder benefits in parity with physical-health benefits, adopt generally accepted standards of care, maintain at least an 85% medical loss ratio for the affected coverage, and file annual parity compliance reports.16

Confidentiality of treatment records

Substance use disorder treatment records carry heightened confidentiality protection under 42 CFR Part 2, which has historically been stricter than HIPAA and generally requires the patient's specific written consent before records are shared.17 A February 16, 2024 federal final rule aligned Part 2 more closely with HIPAA for treatment, payment, and health-care-operations purposes while keeping the core protection in place. For a family helping a loved one, the practical point is that a signed consent lets the care team and the people coordinating care share information.

Georgia's delivery system

DBHDD and Community Service Boards

The Georgia Department of Behavioral Health and Developmental Disabilities (DBHDD) is the state's single authority for behavioral health. It licenses opioid treatment programs, funds services for uninsured Georgians, runs the crisis system, and oversees the Georgia Community Service Boards (CSBs), the county-based agencies that are the most common entry point for low-income Georgians. Most CSBs offer outpatient counseling, intensive outpatient programs, buprenorphine prescribing, treatment for co-occurring mental health conditions, and peer support, and they accept Medicaid for enrolled members.

Care management organizations

Behavioral health is "carved in" to Georgia's Medicaid managed care plans, meaning each plan handles prior authorization, its provider network, and claims for addiction treatment. As of 2026, Georgia Families contracts with three care management organizations: Amerigroup Community Care, CareSource, and Peach State Health Plan. WellCare is no longer a separate Georgia Families plan. A 2024 reprocurement remains in a bid-protest phase with no confirmed go-live date, and the current three-plan contracts have been extended through June 30, 2027.18 All three plans cover the full ASAM continuum subject to medical necessity. For services beyond the Medicaid package, such as residential care longer than the time-limited benefit, DBHDD-funded services can fill gaps.

Pathways to Coverage

Georgia Pathways to Coverage is a limited Medicaid expansion under Section 1115 that launched July 1, 2023 and covers adults aged 19 to 64 with household income up to 100% of the Federal Poverty Level who complete at least 80 hours a month of qualifying activities. CMS extended the program through December 31, 2026.19 Effective October 1, 2025 Georgia eased the rules: members report hours only at application and annual renewal rather than monthly, being the parent or guardian of a Medicaid-enrolled child under age six was added as a qualifying activity (alongside working, job training or education, and volunteering), and retroactive coverage now begins on the first day of the application month. For a Georgian with a substance use disorder who would otherwise be uninsured, Pathways enrollment unlocks the full Medicaid benefit package, including SUD treatment.

Crisis services

Georgia routes crisis care through a single system. Calls, texts, and chats to 988, the national Suicide and Crisis Lifeline, are answered 24 hours a day in Georgia by the Georgia Crisis and Access Line (GCAL), under DBHDD.20 GCAL is the state's single entry point for behavioral health crisis services: it provides phone intervention, can dispatch a mobile crisis team to where a person is, and links callers to crisis stabilization units, inpatient beds, and outpatient or addiction treatment. GCAL's direct number is 1-800-715-4225.

The numbers below are the entry points a Georgia family uses most to reach an assessment or a crisis response.

Reentry coverage for people leaving incarceration

Under a Section 1115 reentry demonstration that CMS opened to states in 2023, a state may, for the first time, cover a limited set of pre-release services for Medicaid-eligible incarcerated people for up to 90 days before their expected release, and that package can include addiction medications.21 This addresses the weeks right after release, the period of highest overdose risk because tolerance has dropped during incarceration. Georgia, like other states, has pursued this pathway; because the specific terms of Georgia's approval are not yet reflected in a verified state source, confirm current covered services and timing with the Georgia Department of Community Health.

Pregnancy and adolescent treatment

Pregnancy Medicaid covers comprehensive substance use disorder treatment, and federal law requires it to be available without the residential-facility restriction during pregnancy. ACOG, SAMHSA, and the National Institute on Drug Abuse all recommend continuing or starting buprenorphine or methadone in pregnancy, because untreated opioid use disorder carries higher risk than treatment. DBHDD's Pregnant, Postpartum, and Specialty Care program provides intensive case management, and Plans of Safe Care for newborns are a support framework, not an automatic child-welfare referral.

For adolescents, buprenorphine is FDA-approved from age 16, and DBHDD operates an adolescent treatment network with outpatient, intensive outpatient, and residential options. Georgia law lets minors age 12 and older consent to their own substance use disorder treatment, and those records are protected under 42 CFR Part 2.

How to Access Substance Use Disorder Treatment

If you or a family member needs treatment, these steps move from first contact to ongoing care. They work whether the person is enrolling in Medicaid for the first time or already has coverage.

Worked examples

Margaret, 72, Savannah: late-onset alcohol use disorder as a dual-eligible

Margaret began drinking heavily after her husband died, and her daughter noticed falls and confusion that the family first attributed to age. Margaret has Medicare and full Georgia Medicaid. Her primary care doctor screened her, diagnosed alcohol use disorder, and referred her for an assessment. She completed a short medically monitored detox, then intensive outpatient treatment, and started acamprosate. Medicare paid first for the medical services and Georgia Medicaid covered the cost-sharing, so Margaret paid nothing out of pocket.2 Her daughter, with a signed consent on file, joins care-coordination calls.

Robert, 68, Macon: prescription-opioid misuse and buprenorphine

Robert was prescribed opioids for chronic back pain and developed opioid use disorder. Because the X-waiver is gone, his primary care physician started him on buprenorphine/naloxone film in the same office, with no need to find a specialty clinic. His monthly extended-release option was available if he preferred fewer doses. As a dual-eligible, he pays nothing for the opioid treatment services delivered through his Medicaid plan.

Larry, 41, Columbus: Pathways enrollment, office-based buprenorphine, and IOP

Larry had cycled through opioid use, overdoses, and incarceration. When his disability application was denied, he enrolled in Pathways to Coverage, which qualified him for full Medicaid. He started buprenorphine with a primary care physician at his local CSB and attends intensive outpatient three times a week, with a peer support specialist and a naloxone kit at home. After six months of stability, he is discussing stepping down to weekly outpatient counseling while staying on medication.

Diane, 55, Athens: alcohol use disorder, residential treatment, and acamprosate

Diane has long-standing alcohol use disorder and early cirrhosis. Her ABD Medicaid covered medically managed detox at a hospital, followed by high-intensity residential treatment under Georgia's Section 1115 demonstration, then a step down to intensive outpatient and monthly visits. She takes acamprosate and her liver function is improving with continued abstinence.

Putting it together

Substance use disorder treatment under Georgia Medicaid is comprehensive: the full ASAM continuum, every FDA-approved medication for opioid and alcohol use disorder, and a delivery system that now lets a primary care doctor prescribe buprenorphine. The practical points for a family are these. Buprenorphine is available through any DEA-registered prescriber, so the old barrier of finding a waivered doctor is gone. Naloxone is covered and also sold over the counter. For an older adult with both Medicare and Medicaid, the two programs coordinate and a full dual-eligible generally pays nothing for opioid treatment services.3 And GCAL at 1-800-715-4225, or 988, is the 24-hour door to a crisis response or a referral. Brevy covers related Georgia Medicaid topics, including behavioral health, mental health drugs, parity, and pregnancy coverage, in companion guides.

Learn More

Find personalized help finding substance use disorder treatment in Georgia at brevy.com.

The information on Brevy.com is for educational purposes only and is not a substitute for professional legal, financial, or medical advice. Rules vary by state and program and change frequently. Always verify with the relevant agency or a qualified professional. Brevy is not a law firm, financial advisor, or healthcare provider.